Physician

Jorge R Brothers, M.D.

According to 2025 Medicare claims, Jorge Brothers, M.D. (NPI: 1841232923) practices urology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is LUBBOCK UROLOGY CLINIC, LLP (NPI: 1629012844; TIN: 751514281) and primary practice location at 79416-3035.

Brothers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 534 traditional Medicare patients, billed 12,978 HCPCS/CPT codes, and received $673,558 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,373 prescription claims across 556 beneficiaries totaling $433,133 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 30 claims. Open Payments data shows 70 records totaling $1,931. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $366,442 and ending at $673,558. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	650	4,764	$366,442
2016	628	5,237	$192,424
2017	576	7,207	$406,423
2018	575	11,865	$659,756
2019	544	12,326	$615,597
2020	479	9,438	$304,083
2021	489	9,867	$268,390
2022	468	12,397	$600,524
2023	548	14,337	$629,355
2024	534	12,978	$673,558

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	468	2,118	$229,416
2016	475	2,195	$214,680
2017	453	2,204	$544,835
2018	476	2,289	$775,196
2019	480	2,440	$936,043
2020	471	2,293	$767,554
2021	485	2,261	$802,452
2022	487	2,166	$746,535
2023	489	2,137	$554,611
2024	556	2,373	$433,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	53	$2,064
2016	N/R	66	$1,257
2017	N/R	88	$1,828
2018	N/R	57	$5,251
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$5,458
2022	N/R	77	$8,458
2023	N/R	60	$10,002
2024	N/R	30	$11,733

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	315	367	$120
84153	Psa (prostate specific antigen) measurement, total	214	291	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	252	312	$12
36415	Insertion of needle into vein for collection of blood sample	269	366	$9
81003	Automated urinalysis test	386	545	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	97	6,263	$92,934
Gemtesa	Vibegron	15	870	$13,877
Mirabegron Er	Mirabegron	22	1,138	$10,704
Estradiol	Estradiol	135	7,160	$10,230
Tamsulosin Hcl	Tamsulosin Hcl	571	46,187	$10,092

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	30	$11,733

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$1,931	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jorge R. Brothers, M.D.?

Tedicare shows public-source Medicare data for Jorge R. Brothers, M.D. (NPI 1841232923), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge R. Brothers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jorge R. Brothers, M.D.?

Jorge R. Brothers, M.D. is linked to LUBBOCK UROLOGY CLINIC, LLP (billing NPI 1629012844) in the available physician profile data.

Does Jorge R. Brothers, M.D. have Open Payments data?

Jorge R. Brothers, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.